Ongoing Clinical Trials
Azenosertib (ZN-c3)
Phase 2 Monotherapy Study in Uterine Serous Carcinoma
Phase 1/2 Monotherapy Study in Cyclin E Driven High Grade Serous Ovarian Cancer
Phase 1 Monotherapy, Dose Optimization Study in Solid Tumors
Phase 1/2 Combination Study of Azenosertib and Gemcitabine in Osteosarcoma
Phase 1/2 Combination Study of Azenosertib and Chemotherapy in Ovarian Cancer
Phase 1/2 Combination Study of Azenosertib and BEACON Regime in Metastatic Colorectal Cancer
Phase 1b Combination Study of Azenosertib and PARPi in PARP Resistant Ovarian Cancer
ZN-d5
Phase 1/2 Monotherapy Study in Relapsed or Refractory Light Chain (AL) Amyloidosis
Phase 1/2 Combination Study of ZN-d5 and Azenosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)